OPKO Health is refocusing on drug development, with most pipeline assets in early stages and limited near-term catalysts.

OPKO Health, Inc. OPK is well positioned for growth in the coming quarters, supported by the potential of RAYALDEE. Optimism ...

OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, supported by the potential of RAYALDEE. The optimism surrounding the stock is backed by RAYALDEE’s performance and strategic ...

OPKO Health, Inc. (NASDAQ:OPK) is one of the High-Flying Penny Stocks to Buy. On March 12, Barrington lowered the firm’s price target on OPKO Health, Inc. (NASDAQ:OPK) from $2.25 to $1.50 and ...

OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, supported by the potential of RAYALDEE. The optimism surrounding the stock is backed by RAYALDEE’s performance and strategic ...

OPKO Health (NASDAQ:OPK) executives said the company exited 2025 with “tremendous momentum,” citing efforts to reposition its ...

MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPK) today announced that its Board of Directors has authorized the repurchase of up to $100 million of shares of the Company's common stock ...

MIAMI (AP) — MIAMI (AP) — Opko Health Inc. (OPK) on Thursday reported a loss of $31.3 million in its fourth quarter. The Miami-based company said it had a loss of 4 cents per share. The results ...

Phillip Frost, Chairman and Chief Executive Officer, will provide opening remarks. Elias Zerhouni, Vice Chairman and ...

MIAMI (AP) — MIAMI (AP) — Opko Health Inc. (OPK) on Wednesday reported third-quarter profit of $21.6 million. On a per-share basis, the Miami-based company said it had net income of 3 cents. The ...